These final results, together with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the strategy of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Problems. Researchers believe that blocking this https://edithw260xat1.blogdomago.com/profile